Mebendazole Market Revenue 2024 to 2034

Mebendazole Market Revenue 2024 to 2034

The mebendazole market, worth USD 0.13 billion in 2024, will expand to USD 0.22 billion by 2034, at 5.6% CAGR, fueled by increasing parasitic infection cases and growing usage in veterinary care.

Report ID: 10486 | Format: Databook | Published: August 2025 | Delivery: Immediate
Download Sample     Customisation Request  

Revenue,

USD 0.13 Bn

Forecast Year,

USD 0.22 Bn

CAGR, 2025 -

5.60%

Report Coverage

Worldwide

Reviewed By

Aditi Shivarkar

Reviewed By

Aman Singh

Mebendazole Market Size Analysis

Mebendazole Market Size By Type 2024 to 2034 (USD )

Type 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Tablet0.090.100.100.110.110.120.130.140.140.150.16
Oral Suspension0.040.040.040.050.050.050.050.060.060.060.06

Mebendazole Market Size By Age Group 2024 to 2034 (USD )

Age Group 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Pediatric0.070.070.070.080.080.090.090.090.100.110.11
Adult0.070.070.070.080.080.090.090.100.100.110.11

Mebendazole Market Size By Region 2024 to 2034 (USD )

Region 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
North America0.030.030.030.030.030.030.040.040.040.040.04
Europe0.030.030.040.040.040.040.050.050.050.060.06
Asia Pacific0.060.060.060.070.070.070.080.080.090.090.09
Latin America0.010.010.010.010.010.010.010.010.010.010.01
Middle East & Africa0.010.010.010.010.010.010.010.010.010.010.01

Mebendazole Market

Mebendazole Market

Our Client